LexGenius Logo
LexGenius
Late-stage / Active MDL2 activitiesPharmaceutical intelligence

Ozempic Gastroparesis

Pharmaceutical · litigation and safety scrutiny around semaglutide products and severe gastrointe…

DEFENDANT

Pharmaceutical

MDL / TRACK

MDL 3094

E.D. Pa.

JUDGE

Various

PLAINTIFFS

Emerging

BELLWETHER / TRIAL

TBD

SETTLEMENT STATUS

Pending

Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity

Case overview

litigation and safety scrutiny around semaglutide products and severe gastrointestinal injuries including gastroparesis

Snapshot generated Mar 10, 2026, 11:39 AM with 2 activity items.

Litigation status

  • MDL 3094 Ozempic gastroparesis
  • semaglutide gastroparesis lawsuit
  • GLP-1 stomach paralysis litigation

Geographic exposure

Coverage follows drug safety notices, clinical literature, MDL activity, and emerging injury allegations tied to prescription products.

Key defendants

semaglutide gastroparesisGLP-1 stomach paralysis

Timeline

Timeline data populates automatically on next enrichment run.

Statute of limitations

State-by-state SOL matrix reserved for source-backed legal research.

Live intelligence

AI litigation brief

Ozempic Gastroparesis remains late-stage / active mdl with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Ozempic Gastroparesis: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Ozempic Gastroparesis: court filing watch. openFDA regulatory on Mar 10: Ozempic Gastroparesis: FDA regulatory alert.

Trajectory

The feed is being driven by court-side movement, so docket scheduling and case-management orders should lead the next editorial update for Ozempic Gastroparesis.

Editorial intelligence

MDL 3094 should stay on the lead docket watch because it is the primary consolidation vehicle for Ozempic Gastroparesis.

Generated Mar 10, 2026, 11:39 AM

PACER

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 3 minutes

Last fetch Mar 10, 2026, 11:36 AM

Next fetch Mar 10, 2026, 12:36 PM

Google News

Live

Target freshness: within 5 minutes of upstream fetch.

Lag 4 minutes

Last fetch Mar 10, 2026, 11:35 AM

Next fetch Mar 10, 2026, 12:35 PM

FAERS

Live

Target freshness: within 15 minutes of upstream fetch.

Lag 11 minutes

Last fetch Mar 10, 2026, 11:28 AM

Next fetch Mar 10, 2026, 12:28 PM

PubMed

Live

Target freshness: within 30 minutes of upstream fetch.

Lag 21 minutes

Last fetch Mar 10, 2026, 11:18 AM

Next fetch Mar 10, 2026, 12:18 PM

2 activities detected

⚖️CourtPACER

Ozempic Gastroparesis: court filing watch

Federal Courts watchlist initialized for Ozempic Gastroparesis. Captions, docket numbers, and venue context are validated before promotion.

AI Litigation Note

PACER court filing on Mar 10 for Ozempic Gastroparesis. Ozempic Gastroparesis: court filing watch — Federal Courts watchlist initialized for Ozempic Gastroparesis. Captions, docket numbers, and venue context are validated before promotion. Monitor docket for scheduling orders, CMOs, and bellwether selections.

Generated Mar 10, 2026, 11:33 AM
Confidence 88%Published Mar 10, 2026, 11:32 AM
View Original Source →
📜RegulatoryFDA

Ozempic Gastroparesis: FDA regulatory alert

openFDA monitoring is active for Ozempic Gastroparesis. FDA safety alerts, recalls, and enforcement reports are tracked via direct API connection.

AI Litigation Note

openFDA regulatory on Mar 10 for Ozempic Gastroparesis. Regulatory developments can change intake posture and motion practice quickly.

Generated Mar 10, 2026, 11:14 AM
Confidence 88%Published Mar 10, 2026, 11:13 AM

LexGenius Ranking

74High Signal

Court, news, and regulatory activity are elevated

Evidence16 / 20
Momentum16 / 20
Exposure14 / 20
Regulatory12 / 20
Legal16 / 20

Monitoring

60 min

refresh interval

Last: Mar 10, 2026, 11:27 AM

Next: Mar 10, 2026, 12:27 PM

Signal feed

2

activities detected

Google NewsPACERFAERSPubMed

AI Brief

Ozempic Gastroparesis remains late-stage / active mdl with 2 current signals in the accepted feed.

Overview

PACER court filing on Mar 10: Ozempic Gastroparesis: court filing watch. This is the lead item in the current accepted signal set.

Key developments

PACER court filing on Mar 10: Ozempic Gastroparesis: court filing watch. openFDA regulatory on Mar 10: Ozempic Gastroparesis: FDA regulatory alert.

Generated Mar 10, 2026, 11:39 AM

Tracked MDLs

MDL 3094

E.D. Pa.

Gastroparesis and gastrointestinal injury track

← Previous

Lyft Assault

Monitors Lyft passenger-assault litigation, safety-policy responses, and public reporting involving Lyft.

Next →

Ozempic NAION

Tracks Ozempic NAION and vision-loss litigation tied to semaglutide products.